The U.S. Department of Justice recently filed a lawsuit against ValueAct Capital and its affiliates for allegedly violating U.S. antitrust laws in connection with their purchase of approximately $2.5 billion of voting shares of Houston-based Halliburton and Baker Hughes.
The DOJ’s prosecution centers on the issue of whether ValueAct Capital and its affiliates (known collectively as ValueAct) violated the reporting and waiting period requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the HSR Act) in its recent purchase of the stock. The DOJ Antitrust Division filed the civil antitrust lawsuit in the U.S. District Court for the Northern District of California. The DOJ lawsuit seeks civil penalties and an injunction against further HSR Act violations.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
